Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 38 Records) |
| Query Trace: Anemia and TP53[original query] |
|---|
| Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget 2018 Jun 9 (45): 27882-27894. Kuendgen Andrea, Müller-Thomas Catharina, Lauseker Michael, Haferlach Torsten, Urbaniak Petra, Schroeder Thomas, Brings Carolin, Wulfert Michael, Meggendorfer Manja, Hildebrandt Barbara, Betz Beate, Royer-Pokora Brigitte, Gattermann Norbert, Haas Rainer, Germing Ulrich, Götze Katharina |
| LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases. Breast cancer research and treatment 2018 Jun . Van Swearingen Amanda E D, Siegel Marni B, Deal Allison M, Sambade Maria J, Hoyle Alan, Hayes D Neil, Jo Heejoon, Little Paul, Dees Elizabeth Claire, Muss Hyman, Jolly Trevor, Zagar Timothy M, Patel Nirali, Miller C Ryan, Parker Joel S, Smith J Keith, Fisher Julie, Shah Nikita, Nabell Lisle, Nanda Rita, Dillon Patrick, Abramson Vandana, Carey Lisa A, Anders Carey |
| Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
| The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia. American journal of hematology 2019 Jul . Zheng Gang, Chen Ping, Pallavajjalla Aparna, Haley Lisa, Gondek Lukasz, Dezern Amy, Ling Hua, De Marchi Federico, Lin Ming-Tseh, Gocke Christoph |
| Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan. Cancer science 2019 3 110 (5): 1686-1694. Munakata Wataru, Ando Kiyoshi, Hatake Kiyohiko, Fukuhara Noriko, Kinoshita Tomohiro, Fukuhara Suguru, Shirasugi Yukari, Yokoyama Masahiro, Ichikawa Satoshi, Ohmachi Ken, Gion Naokazu, Aoi Arata, Tobinai Kens |
| TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia 2019 Jan . Haase Detlef, Stevenson Kristen E, Neuberg Donna, Maciejewski Jaroslaw P, Nazha Aziz, Sekeres Mikkael A, Ebert Benjamin L, Garcia-Manero Guillermo, Haferlach Claudia, Haferlach Torsten, Kern Wolfgang, Ogawa Seishi, Nagata Yasunobu, Yoshida Kenichi, Graubert Timothy A, Walter Matthew J, List Alan F, Komrokji Rami S, Padron Eric, Sallman David, Papaemmanuil Elli, Campbell Peter J, Savona Michael R, Seegmiller Adam, Adès Lionel, Fenaux Pierre, Shih Lee-Yung, Bowen David, Groves Michael J, Tauro Sudhir, Fontenay Michaela, Kosmider Olivier, Bar-Natan Michal, Steensma David, Stone Richard, Heuser Michael, Thol Felicitas, Cazzola Mario, Malcovati Luca, Karsan Aly, Ganster Christina, Hellström-Lindberg Eva, Boultwood Jacqueline, Pellagatti Andrea, Santini Valeria, Quek Lynn, Vyas Paresh, Tüchler Heinz, Greenberg Peter L, Bejar Rafael, |
| FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2020 7 42 (7): 1010428320938494. Costa Ericka Francislaine Dias, Lima Tathiane Regine Penna, Lopes-Aguiar Leisa, Nogueira Guilherme Augusto Silva, Visacri Marília Berlofa, Quintanilha Julia Coelho França, Pincinato Eder Carvalho, Calonga Luciane, Mariano Fernanda Viviane, Altemani Albina Messias de Almeida Milani, Altemani João Maurício Carrasco, Moriel Patrícia, Chone Carlos Takahiro, Ramos Celso Dario, Lima Carmen Silvia Pass |
| Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals. Blood 2020 4 135 (14): 1161-1170. van Zeventer Isabelle A, de Graaf Aniek O, Wouters Hanneke J C M, van der Reijden Bert A, van der Klauw Melanie M, de Witte Theo, Jonker Marianne A, Malcovati Luca, Jansen Joop H, Huls Gerw |
| Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. Scientific reports 2020 2 10 (1): 3080. Wang Yudong, Janku Filip, Piha-Paul Sarina, Hess Kenneth, Broaddus Russell, Liu Lidong, Shi Naiyi, Overman Michael, Kopetz Scott, Subbiah Vivek, Naing Aung, Hong David, Tsimberidou Apostolia M, Karp Daniel, Yao James, Fu Siqi |
| Germline mutations in a DNA repair pathway are associated with familial colorectal cancer. JCI insight 2021 9 6 (18): . Xu Pingping, Sun Danfeng, Gao Yaqi, Jiang Yi, Zhong Ming, Zhao Gang, Chen Jinxian, Wang Zheng, Liu Qiang, Hong Jie, Chen Haoyan, Chen Ying-Xuan, Fang Jing-Yu |
| The prevalence of HLA-I LOH in Chinese pan-cancer patients and genomic features of patients harboring HLA-I LOH. Human mutation 2021 7 42 (10): 1254-1264. Zhao Jian, Xiao Xiaoxiong, Li Yue, Gao Xuan, Zhang Xiuqin, Liu Zeyi, Yi Yuting, Fu Xiaorui, Wang Han, Guan Yanfang, Xia Xuefeng, Zhang Weixing, Huang Jian' |
| Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype, TP53 deletion, and TP53 mutations. Leukemia & lymphoma 2021 4 62 (10): 2466-2474. Wang Nan, Yuan Lijun, Jing Yu, Fan Keke, Jin Hongshi, Lv Chao, Wang Lili, Yu |
| Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer. Frontiers in oncology 2021 11 637431. Zeng Bing, Huang Peide, Du Peina, Sun Xiaohui, Huang Xuanlin, Fang Xiaodong, Li L |
| Germline mutations and age at onset of lung adenocarcinoma. Cancer 2021 4 127 (15): 2801-2806. Reckamp Karen L, Behrendt Carolyn E, Slavin Thomas P, Gray Stacy W, Castillo Danielle K, Koczywas Marianna, Cristea Mihaela C, Babski Kirsten M, Stearns Donna, Marcum Catherine A, Rodriguez Yenni P, Hass Amie J, Vecchio Mary M, Mora Pamela, Cervantes Aleck E, Sand Sharon R, Mejia Rosa M, Tsou Terrence C, Salgia Ravi, Weitzel Jeffrey |
| Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 3809-3815. Nairuz Tahsin, Bushra Yearul Umme, Kabir Year |
| A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2021 12 163 19-26. Plummer Ruth, Dean Emma, Arkenau Hendrik-Tobias, Redfern Charles, Spira Alexander I, Melear Jason M, Chung Ki Y, Ferrer-Playan Jordi, Goddemeier Thomas, Locatelli Giuseppe, Dong Jennifer, Fleuranceau-Morel Patricia, Diaz-Padilla Ivan, Shapiro Geoffrey |
| Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose-response : a publication of International Hormesis Society 0 20 (2): 15593258221111666. Spasic Jelena, Cavic Milena, Stanic Nemanja, Zaric Bojan, Kovacevic Tomi, Radosavljevic Davorin, Nagorni-Obradovic Ljudmi |
| Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients. Leukemia research 2022 Jun 117 106854. Hegazi Heba M, Elghonemy M S, El-Baiomy M A, Soliman Eman A, Abdel-Hady Elsayed |
| Prediction of survival with intensive chemotherapy in acute myeloid leukemia. American journal of hematology 2022 4 97 (7): 865-876. Sasaki Koji, Ravandi Farhad, Kadia Tapan, DiNardo Courtney, Borthakur Gautam, Short Nicholas, Jain Nitin, Daver Naval, Jabbour Elias, Garcia-Manero Guillermo, Khoury Joseph, Konoplev Sergej, Loghavi Sanam, Patel Keyur, Montalban-Bravo Guillermo, Masarova Lucia, Konopleva Marina, Kantarjian Hag |
| STEREOTYPED CASES IN UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS DEPENDING ON THE IONIZING RADIATION EXPOSURE. Problemy radiatsiinoi medytsyny ta radiobiolohii 2022 12 27 307-323. Bilous N I, Abramenko I V, Chumak A A, Dyagil I S, Martina Z |
| Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 1 40 (11): 1196-1205. Giné Eva, de la Cruz Fátima, Jiménez Ubieto Ana, López Jimenez Javier, Martín García-Sancho Alejandro, Terol M José, González Barca Eva, Casanova María, de la Fuente Adolfo, Marín-Niebla Ana, Muntañola Ana, González-López Tomás José, Aymerich Marta, Setoain Xavier, Cortés-Romera Montserrat, Rotger Amanda, Rodríguez Sonia, Medina Herrera Alejandro, García Sanz Ramón, Nadeu Ferran, Beà Silvia, Campo Elías, López-Guillermo Arman |
| Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 9 JCO2202604. Naval G Daver, Paresh Vyas, Suman Kambhampati, Monzr M Al Malki, Richard A Larson, Adam S Asch, Gabriel Mannis, Wanxing Chai-Ho, Tiffany N Tanaka, Terrence J Bradley, Deepa Jeyakumar, Eunice S Wang, Kendra Sweet, Hagop M Kantarjian, Guillermo Garcia-Manero, Rami Komrokji, Guan Xing, Giridharan Ramsingh, Camille Renard, Joshua F Zeidner, David A Sallm |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
| Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 . Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, Noel Laudi, Mary W Redman, Jhanelle E Gray, David R Gandara, Karen Kel |
| Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study. Journal of thoracic disease 2023 5 15 (4): 2003-2011. Xuanting Ye, Aimi Huang, Yan Zhou, Yanbin Kuang, Weimin Wang, Aiqin Gu, Ling |
| Clinical implications of myeloid malignancy?related somatic mutations in aplastic anemia. Clinical and experimental medicine 2023 4 . Lingling Liu, Danfeng Zhang, Qiuhao Fu, Jingdi Wang, Jifeng Yu, Dandan Chen, Fang Wang, Rong Guo, Xinsheng Xie, Zhongxing Jiang, Yingmei |
| Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
| The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis. Journal of translational medicine 2023 12 21 (1): 874. Wei Wei, Fangfang Shi, Yang Xu, Yang Jiao, Ying Zhang, Qiuxiang Ou, Xue Wu, Lingyi Yang, Jinhuo L |
| Genomic alterations in two patients with esophageal carcinosarcoma identified by whole genome sequencing: a case report. Surgical case reports 2024 8 10 (1): 191. Masazumi Inoue, Yasuhiro Tsubosa, Sumiko Ohnami, Kazunori Tokizawa, Shuhei Mayanagi, Keiichi Ohshima, Kenichi Urakami, Shumpei Ohnami, Takeshi Nagashima, Ken Yamaguc |
| Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets. Journal of thoracic disease 2024 1 15 (12): 6796-6805. Wen Ouyang, Jing Yu, Zihang Zeng, Jun Gong, Junhong Zhang, Conghua X |
- Page last reviewed:Feb 1, 2024
- Content source: